Making regulatory changes for opioids in Australia is no quick fix when it comes to helping save more lives and better manage pain. Doctors Ben O’Mara and Megan Weier explain what changes work best.
Earlier this month, the Australian government made changes to rules of the Pharmaceutical Benefits Scheme (PBS), increasing restrictions on the use of codeine, morphine, oxycodone, fentanyl and other opioid-based prescription medications.
The restrictions include smaller opioid pack sizes, and doctors and other prescribers needing to complete more procedures in order to prescribe the drugs.
Subscribe for unlimited access
A Mandarin Premium subscription gives you access to all articles, webinars, discounted early-bird event invites and more.
INTRO OFFER - 40% OFF
ANNUAL $440$264
Save 40% on premium access for new accounts.
Just $22/month for your first year.
Renews at $440/year until cancelled.
MONTHLY $44
Unlimited access for just $10 per week. Cancel anytime.
Any feedback or news tips? Here’s where to contact the relevant team.